Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge

We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6–7 days, and 79% had rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Nori, Priya, Cowman, Kelsie, Chen, Victor, Bartash, Rachel, Szymczak, Wendy, Madaline, Theresa, Punjabi Katiyar, Chitra, Jain, Ruchika, Aldrich, Margaret, Weston, Gregory, Gialanella, Philip, Corpuz, Marilou, Gendlina, Inessa, Guo, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417979/
https://www.ncbi.nlm.nih.gov/pubmed/32703320
http://dx.doi.org/10.1017/ice.2020.368
Descripción
Sumario:We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6–7 days, and 79% had received prior antibiotics. Metallo-β-lactamase–producing E. cloacae coinfections occurred in 5 patients.

Ejemplares similares